Source: Medical Product Outsourcing

Kryptos Biotechnologies: Kryptos Secures Funding to Study its POC Molecular Diagnostics System

Strategic Investor Osang Healthcare will partner with the company to manufacture and distribute the product.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jinyong Lee's photo - Co-Founder & CEO of Kryptos Biotechnologies

Co-Founder & CEO

Jinyong Lee

CEO Approval Rating

90/100

Read more